Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 2Peripheral Nervous System Diseases 1Ototoxicity 1Neoplasms, Cystic, Mucinous, and Serous 1Hearing Loss, Sensorineural 1Hearing Loss 1Head and Neck Neoplasms 1Ear Diseases 1Deafness 1Carcinoma, Hepatocellular 1Adenocarcinoma, Mucinous 1

Interventions

Paclitaxel 1Chemoradiotherapy 1Bromelains 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms, Cystic, Mucinous, and Serous × Acetylcysteine × Clear all
NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Mucpharm Pty Ltd

Phase 2 Unknown
62 enrolled

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡